Literature DB >> 15716064

The effect of a late evening snack in patients with liver cirrhosis.

Masako Tsuchiya1, Isao Sakaida, Mariko Okamoto, Kiwamu Okita.   

Abstract

OBJECTIVES: : As an intervention for energy malnutrition, frequent meals or a late evening snack (LES) has been recently recommended. On the other hand, it has been reported that glucose intolerance is found in approximately 70% of patients with liver cirrhosis. Thus, we investigated which would be better for the improvement of energy malnutrition and glucose intolerance, treatment with LES alone or LES plus divided meals.
METHODS: : One group of oral supplementation with one pack of a branched-chain amino acid (BCAA)-enriched nutrient, Aminoleban EN (210kcal), at 10 p.m. LES and the other group with two packs of Aminoleban EN (one pack at 10 p.m. as LES and another pack during the day, i.e. at sometime from 10 a.m. to 3 p.m.) were examined to determine the influence of LES on the blood glucose level, biochemical parameters, and energy metabolism. Twenty-six patients participated in this study. The administration period was 7 days. Metabolic measurements were performed using an indirect calorimeter.
RESULTS: : The fat oxidation rate was significantly decreased and the carbohydrate oxidation rate significantly increased in both groups. As a result, respiratory quotient (RQ) was significantly improved. In many cases, the increase of the glucose level after meals seemed to be reduced after LES administration for 1 week. LES could improve energy malnutrition, and correct amino acid imbalance. There was also a significant correlation between non-protein respiratory quotient (npRQ) and the creatinine height index.
CONCLUSION: : LES alone improved the energy malnutrition state and glucose intolerance equivalent to LES plus divided meals. Thus, LES may improve glucose intolerance in patients with liver cirrhosis.

Entities:  

Year:  2005        PMID: 15716064     DOI: 10.1016/j.hepres.2004.11.009

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  14 in total

Review 1.  Perioperative nutritional therapy in liver transplantation.

Authors:  Ahmed Hammad; Toshimi Kaido; Shinji Uemoto
Journal:  Surg Today       Date:  2014-01-29       Impact factor: 2.549

2.  The efficacy of nocturnal administration of branched-chain amino acid granules to improve quality of life in patients with cirrhosis.

Authors:  Hisashi Hidaka; Takahide Nakazawa; Shinji Kutsukake; Yoshiki Yamazaki; Izumi Aoki; Shiro Nakano; Noriyuki Asaba; Tsutomu Minamino; Juichi Takada; Yoshiaki Tanaka; Yusuke Okuwaki; Masaaki Watanabe; Akitaka Shibuya; Wasaburo Koizumi
Journal:  J Gastroenterol       Date:  2012-07-24       Impact factor: 7.527

3.  Estimation of protein intake using urinary urea nitrogen in patients with early-stage liver cirrhosis.

Authors:  Yohei Kida; Hiroki Ueda; Hiroto Tanaka; Masakazu Ichinose
Journal:  Hepatol Int       Date:  2007-09-22       Impact factor: 6.047

Review 4.  Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization.

Authors:  Takumi Kawaguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

5.  Short-term reductions in non-protein respiratory quotient and prealbumin can be associated with the long-term deterioration of liver function after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.

Authors:  Masaya Saito; Yasushi Seo; Yoshihiko Yano; Akira Miki; Masaru Yoshida; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2012-02-18       Impact factor: 7.527

Review 6.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 7.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  Transl Gastroenterol Hepatol       Date:  2018-07-30

Review 8.  Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function.

Authors:  Taro Takami; Takahiro Yamasaki; Issei Saeki; Toshihiko Matsumoto; Yutaka Suehiro; Isao Sakaida
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

9.  Nutrition therapy for liver diseases based on the status of nutritional intake.

Authors:  Kenichiro Yasutake; Motoyuki Kohjima; Manabu Nakashima; Kazuhiro Kotoh; Makoto Nakamuta; Munechika Enjoji
Journal:  Gastroenterol Res Pract       Date:  2012-11-14       Impact factor: 2.260

10.  Reduction in non-protein respiratory quotient is related to overall survival after hepatocellular carcinoma treatment.

Authors:  Masaya Saito; Yasushi Seo; Yoshihiko Yano; Kenji Momose; Hirotaka Hirano; Masaru Yoshida; Takeshi Azuma
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.